Matutino, A., Amaro, C., & Verma, S. (2018). CDK4/6 inhibitors in breast cancer: Beyond hormone receptor-positive HER2-negative disease. Ther Adv Med Oncol.
Citação norma ChicagoMatutino, Adriana, Carla Amaro, and Sunil Verma. "CDK4/6 Inhibitors in Breast Cancer: Beyond Hormone Receptor-positive HER2-negative Disease." Ther Adv Med Oncol 2018.
MLA CitationMatutino, Adriana, Carla Amaro, and Sunil Verma. "CDK4/6 Inhibitors in Breast Cancer: Beyond Hormone Receptor-positive HER2-negative Disease." Ther Adv Med Oncol 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.